August 16, 2019
The Ministry of Health, Labor and Welfare (MHLW) withdrew orphan drug designation on August 13 for Zenyaku Kogyo/Chugai Pharmaceutical’s anticancer drug Rituxan (rituximab) for the indication of acquired thrombotic thrombocytopenic purpura. The withdrawal came as the MHLW’s Council on Unapproved...read more